BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11148045)

  • 1. Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation.
    Ablooglu AJ; Kohanski RA
    Biochemistry; 2001 Jan; 40(2):504-13. PubMed ID: 11148045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation.
    Cann AD; Bishop SM; Ablooglu AJ; Kohanski RA
    Biochemistry; 1998 Aug; 37(32):11289-300. PubMed ID: 9698376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-determining steps for tyrosine phosphorylation by the kinase domain of v-fps.
    Wang C; Lee TR; Lawrence DS; Adams JA
    Biochemistry; 1996 Feb; 35(5):1533-9. PubMed ID: 8634284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain.
    Ablooglu AJ; Frankel M; Rusinova E; Ross JB; Kohanski RA
    J Biol Chem; 2001 Dec; 276(50):46933-40. PubMed ID: 11598120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic evidence for activating and non-activating components of autophosphorylation of the insulin receptor protein kinase.
    Kohanski RA; Lane MD
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1312-8. PubMed ID: 3004488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-receptor tyrosine kinase and glucose transport.
    Lane MD; Flores-Riveros JR; Hresko RC; Kaestner KH; Liao K; Janicot M; Hoffman RD; McLenithan JC; Kastelic T; Christy RJ
    Diabetes Care; 1990 Jun; 13(6):565-75. PubMed ID: 2162754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.
    Frankel M; Ablooglu AJ; Leone JW; Rusinova E; Ross JB; Heinrikson RL; Kohanski RA
    Mol Cell Biol; 2001 Jul; 21(13):4197-207. PubMed ID: 11390649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes in the activation loop of the insulin receptor's kinase domain.
    Frankel M; Bishop SM; Ablooglu AJ; Han YP; Kohanski RA
    Protein Sci; 1999 Oct; 8(10):2158-65. PubMed ID: 10548062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation dependent destabilization of the insulin receptor kinase domain: tryptophan-1175 reports changes in the catalytic cleft.
    Bishop SM; Ross JB; Kohanski RA
    Biochemistry; 1999 Mar; 38(10):3079-89. PubMed ID: 10074361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
    Hawkins J; Marcy A
    Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction.
    Cobb MH; Sang BC; Gonzalez R; Goldsmith E; Ellis L
    J Biol Chem; 1989 Nov; 264(31):18701-6. PubMed ID: 2808393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state kinetic characterization of kinase activity and requirements for Mg2+ of interleukin-1 receptor-associated kinase-4.
    Hekmat-Nejad M; Cai T; Swinney DC
    Biochemistry; 2010 Feb; 49(7):1495-506. PubMed ID: 20104875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the activation loop tyrosine of the oncoprotein v-Fps.
    Saylor P; Hanna E; Adams JA
    Biochemistry; 1998 Dec; 37(51):17875-81. PubMed ID: 9922154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
    Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
    Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of the oncoprotein v-Fps: site-specific mutagenesis of the putative P+1 pocket.
    Konkol L; Hirai TJ; Adams JA
    Biochemistry; 2000 Jan; 39(1):255-62. PubMed ID: 10625501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
    Wu H; Zheng Y; Wang ZX
    Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state.
    Chatti K; Farrar WL; Duhé RJ
    Biochemistry; 2004 Apr; 43(14):4272-83. PubMed ID: 15065871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity.
    Li SL; Yan PF; Paz IB; Fujita-Yamaguchi Y
    Biochemistry; 1992 Dec; 31(49):12455-62. PubMed ID: 1334428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic assessment of the glycine-rich loop of the v-Fps oncoprotein using site-directed mutagenesis.
    Hirai TJ; Tsigelny I; Adams JA
    Biochemistry; 2000 Oct; 39(43):13276-84. PubMed ID: 11052681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of insulin receptor autophosphorylation by polypeptide substrates: inhibition and stimulation by interaction with the catalytic subunit.
    Kohanski RA; Schenker E
    Biochemistry; 1991 Mar; 30(9):2406-14. PubMed ID: 1848096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.